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Abstract: Background. The purpose of this study was to
deﬁne the optimal surgical strategy for sinonasal inverted pap-
illoma in relation to the site of origin and tumor extent.
Methods. Retrospective analysis of patients affected by
inverted papilloma treated by purely endoscopic or combined
approaches at the Department of Otorhinolaryngology of the
University of Brescia and Pavia–Varese from November 1991
to December 2007.
Results. Two hundred twelve patients were considered eli-
gible for this study. An exclusive endoscopic approach was
performed in 198 patients (93.4%); the remaining 14 patients
(6.6%) underwent an endoscopic approach combined with an
osteoplastic frontal ﬂap. Follow-up ranged from 24 to 192
months (mean, 53.8 months). A single recurrence was
observed in 12 patients (5.7%). Twenty complications (9.4%)
were observed.
Conclusion. Endoscopic surgery is the ﬁrst choice in the
treatment of inverted papilloma; only lesions with extensive
involvement of frontal sinus and/or supraorbital cell may
require a combined approach. A minimum follow-up of 5 years
is recommended. VC 2010 Wiley Periodicals, Inc. Head Neck
33: 1154–1161, 2011
Keywords: endoscopic sinus surgery; frontal sinus; inverted
papilloma; osteoplastic frontal ﬂap; complications
Sinonasal inverted papilloma is a benign lesion origi-
nating from the Schneiderian membrane of the mu-
cosa that lines the nasal cavity and paranasal
sinuses.1,2 First described in the 1850s,3,4 the main
biological features of inverted papilloma (the tendency
to cause bone remodeling, propensity to recurrence,
and association with squamous cell carcinoma [SCC])
have been precisely documented, although its etiology
remains a matter of debate.
Surgery is the mainstay of treatment for inverted
papilloma; before the endoscopic era, medial maxillec-
tomy by lateral rhinotomy or midfacial degloving was
considered the gold standard to ensure complete local
resection.5–7 It is worth mentioning that these
approaches, even though providing a much lower recur-
rence rate than simple transnasal resection not assisted
by any optical aid, were also associated with a non-neg-
ligible morbidity.8,9 Since the end of the 1980s, due to
the development of rigid endoscopic ﬁbers and dedi-
cated instruments together with the increase in surgi-
cal expertise, minimally invasive endoscopic approaches
gradually replaced ‘‘traditional’’ external procedures for
the excision of inverted papilloma. This evolution has
clearly shown to be associated with a decreased morbid-
ity and a similar success rate.1,9–11 At present, a purely
transnasal endoscopic approach may be considered the
gold standard in treatment of the vast majority of
inverted papilloma,2,11–13 whereas only a minority of
cases require a combined or external approach.
The present study reports the experience at 2 uni-
versity centers with a uniform policy in management of
inverted papilloma. Particular emphasis was placed on
the deﬁnition of the optimal surgical strategy and tech-
nique in lesions arising in or involving the frontal and
maxillary sinus. Preoperative diagnostic workup, fol-
low-up strategy, and outcome will also be discussed.
MATERIALS AND METHODS
A retrospective analysis of a database dedicated to
patients with inverted papilloma treated at the
Department of Otorhinolaryngology at the University
of Brescia and Pavia–Varese from November 1991 to
December 2009 was performed.
Information on previous surgery, imaging ﬁnd-
ings, sex, age, symptoms at diagnosis, site of origin
and extension of the lesion, surgical approach, associ-
ation with malignancy, and re-treatment in case of
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recurrence was available. Only patients treated by a
purely endoscopic or combined (endoscopic associated
with external) approach and with at least 2 years of
follow-up were considered eligible for inclusion in the
study.
Preoperative Evaluation. Preoperative imaging by
CT and/or MRI with contrast medium administration
was obtained in all cases. An endoscope-guided biopsy
with the patient under local anesthesia was subse-
quently obtained.
Surgical Technique, Exclusion Criteria for Endoscopic
Resection, and Staging. All surgical procedures
were performed with the patient under general anes-
thesia. The entity of dissection was modulated in rela-
tion to the site and extent of the lesion deﬁned by
preoperative imaging and intraoperative ﬁndings.
Informed consent about the possibility of intraopera-
tively switching from an endoscopic to a combined
approach was obtained in patients with different
modalities of frontal sinus and/or supraorbital cell
involvement.
Nasoethmoidal and maxillary sinus inverted pap-
illomas were treated according to 3 different types of
endoscopic procedures, which have been extensively
described in a previous publication (Table 1).14 How-
ever, several details of surgical technique should be
highlighted. Although en bloc resection is only occa-
sionally feasible due to tumor bulk and/or location in
poorly accessible spaces, the lesion was not removed
according to a simple ‘‘piecemeal’’ method but with a
more complex ‘‘modular’’ technique. This means that
the goal of complete excision was achieved by disas-
sembling the lesion in oriented blocks, starting from
the endonasal portion and progressively reaching the
area of attachment where the dissection was carried
along the subperiosteal plane with drilling of the
underlying bone. This modular resection implies that
all the involved subsites with possible foci of microin-
vasive or invasive SCC can be perfectly located at de-
ﬁnitive histology.
One of the most critical issues in surgery for
inverted papilloma is the modality of involvement of
the frontal sinus. Preoperative imaging is often not
accurate enough to identify the site of origin and to
clarify the extent of involvement of the frontal sinus or
recess mucosa, which can be assessed only intraopera-
tively. When the inverted papilloma extended from the
ethmoid into the frontal recess and/or sinus in a ﬁnger-
like manner, a type IIa frontal sinusotomy according to
Draf’s15 classiﬁcation was performed. Whenever the
inverted papilloma was found to originate at the level
of frontal recess, a type IIb frontal sinusotomy was
used. In patients with lesions arising from the mucosa
of the posterior wall of the frontal sinus, a type III fron-
tal sinusotomy, according to Draf,15 was used. If the tu-
mor extended to a supraorbital cell with a limited
lateral extent, exposure was increased by laterally dis-
placing the orbital content after coagulating and sec-
tioning the anterior ethmoid artery before drilling the
upper part of the lamina papyracea.16 Whenever exten-
sive mucosal involvement inside a supraorbital cell
extending far laterally over the orbit or a massive
involvement of the frontal sinus mucosa was identiﬁed,
an osteoplastic ﬂap (OPF) using a coronal approach
was required (Figure 1). Frozen sections were exten-
sively used to assess the radicality of resection.
On the basis of radiological and surgical ﬁndings,
lesions were staged according to the system of
Krouse.17
Perioperative Management and Follow-Up. Pa-
tients were administered antibiotic therapy with
amoxicillin-clavulanate (2 gm/day for 10 days) and
deﬂazacort (15 days, tapering the dose from 30 to 7.5
mg). Irrigations with saline solution (twice daily)
were recommended for at least 1 month. All patients
were postoperatively followed by periodical endoscopic
examinations (every 4 months during the ﬁrst postop-
erative year, every 6 months for at least 4 years, and
then once a year thereafter). Whenever sectioning of
the nasolacrimal duct was performed, irrigation of
the residual lacrimal pathway was performed at the
end of surgery, after removal of nasal packing, and 15
days later to favor its patency. A lacrimal stent was
never placed during primary procedures. Postopera-
tive MRI evaluation was scheduled in the presence of
scar tissue obscuring the visualization of the site of
origin of the lesion (every 6 months for the ﬁrst 2
years and then once a year for the following 3 years)





1 Anterior and posterior ethmoidectomy, sphe-
noidotomy, large middle antrostomy, partial
or complete middle turbinectomy, frontal
sinusotomy (type I, IIA, IIB, or III according
to Draf’s15 classiﬁcation in relation to the
extent of disease).
2 Anterior and posterior ethmoidectomy, sphe-
noidotomy, medial maxillectomy, partial or
complete middle turbinectomy, frontal sinus-
otomy (type I, IIA, IIB, or III according to
Draf’s15 classiﬁcation in relation to the extent
of the disease;  naso-lacrimal duct
section).
3 Anterior and posterior ethmoidectomy, sphe-
noidotomy, endonasal Denker operation with
naso-lacrimal duct section, complete inferior
and middle turbinectomy, frontal sinusotomy
(type I, IIA, IIB, or III according to Draf’s15
classiﬁcation in relation to the extent of
disease).
Endoscopic Approach for Sinonasal Inverted Papilloma HEAD & NECK—DOI 10.1002/hed August 2011 1155
or when synchronous invasive SCC was detected at
deﬁnitive histology (every 4 months for the ﬁrst year,
then every 6 months for the following 4 years). When-
ever an inﬂammatory complication such as frontal si-
nusitis or mucocele was suspected, a CT was
performed. In the presence of epiphora, a dacryocys-
tography was obtained.
Statistical Analysis. A commercially available com-
puter software package (SPSS for Windows, Version
10.01, 1999; SPSS, Chicago, IL) was used. Statistical
analysis was performed using the Kaplan–Meier
method to evaluate the risk of recurrence in relation
to previous surgery, site of origin, and staging of the
lesion. Univariate comparisons between groups were
performed using the log-rank test. A value of p  .05
was considered statistically signiﬁcant.
RESULTS
Patient Data. A total of 307 patients were treated
with a purely endoscopic or combined approach; 212
patients (167 men, 45 women) fulﬁlled inclusion crite-
ria and were considered eligible for the present study.
The remaining 95 patients were followed up for less
than 24 months and, therefore, were not included in
the analysis. Mean age at surgery was 56.5 years
(range, 20–86 years). Fifty-six patients (26.4%) had
been previously treated at other institutions with en-
doscopic (21.4%) or external (5%) approaches. Unilat-
eral nasal obstruction was the presenting symptom in
89.9% of patients; other complaints included hypo-
smia-anosmia (18.7%), rhinorrhea (18.2%), headache
(17.3%), epistaxis (11.8%), and epiphora (6%). The di-
agnosis was serendipitous in 7 asymptomatic patients
(3%). An MRI was obtained in 176 cases (83%); in 91
cases (42.9%), a CT had been performed before the
patient was sent to our institution. The remaining 36
patients (17%) underwent a CT scan only because of
claustrophobia or the presence of a pacemaker.
In 100 patients (47.2%), the lesion originated from
the nasoethmoidal complex, in 92 patients (43.4%)
from the maxillary sinus, in 11 patients (5.2%) from
the frontal, and in 9 patients (4.2%) from the sphe-
noid. Bilateral involvement was present in 7 patients
(3.3%).
Surgical Technique and Staging. An exclusive en-
doscopic approach was used in 198 patients (93.4%):
88 patients (44.4%) received a type 1 resection, 62
patients (31.3%) received a type 2 (with resection of
the nasolacrimal duct in 38 cases), and 48 patients
(24.3%) received a type 3. Fourteen patients (6.6%)
underwent an endoscopic approach combined with an
OPF.
In the 11 patients with frontal sinus inverted pap-
illoma, surgery included a transnasal endoscopic
approach combined with OPF in 5 cases, a Draf III
frontal sinusotomy in 4, and a Draf IIB in 2. More-
over, in addition to the 11 cases in which the tumor
originated from the mucosa of the frontal sinus, we
observed 16 patients with different secondary involve-
ment of the frontal sinus by a nasoethmoidal lesion.
In this group, a Draf IIB frontal sinusotomy was per-
formed in 7 patients, an endoscopic approach was
combined with an OPF in 7 patients, and a Draf III
frontal sinusotomy was performed in 2 patients.
Lesions were staged according to Krouse17 as fol-
lows: 16 (7.5%) T1, 78 (36.8%) T2, 104 (49.1%) T3,
and 14 (6.6%) T4.
Histology. Deﬁnitive histology was consistent with
sinonasal inverted papilloma in all cases; areas of
mild dysplasia was identiﬁed in 3 patients (1.4%) and
moderate dysplasia was identiﬁed in 2 patients
FIGURE 1. Contrast-enhanced MR images, on coronal (A), sagittal (B), and axial (C) plane in a patient who had been previously
treated with a purely endoscopic approach at another institution. Left fronto-ethmoid inverted papilloma completely ﬁlls the frontal sinus
and extends within a supraorbital cell (SO). Massive bone remodeling at the level of orbital roof (arrows in A) and anterior frontal sinus
wall (arrows in B) is evident.
1156 Endoscopic Approach for Sinonasal Inverted Papilloma HEAD & NECK—DOI 10.1002/hed August 2011
(0.9%). Carcinoma in situ was detected in 3 patients
(1.4%) and SCC in 8 patients (3.8%).
Adjuvant Treatment. In 5 patients with SCC, post-
operative radiation therapy (60–65 Gy) on the pri-
mary site was planned.
Complications and Follow-Up. Immediate postoper-
ative complications were observed in 8 patients
(3.8%), 7 after exclusive endoscopic approaches and 1
after following a combined approach. Six patients had
a cerebrospinal ﬂuid (CSF) leak that was intraopera-
tively identiﬁed and treated by endoscopic duraplasty.
Two patients required revision endoscopic surgery
while under general anesthesia for postoperative
epistaxis.
Follow-up data were available for all patients and
ranged from 24 to 192 months (mean 53.8). Delayed
complications were identiﬁed in 12 patients (5.7%). In
6 patients, a CT scan showed the presence of a muco-
cele (4 in the frontal sinus and 2 in the maxillary
sinus). All underwent successful endoscopic marsupi-
alization. In 4 cases, post-saccal lacrimal pathway
obstruction was treated by endonasal dacryocystorhi-
nostomy with lacrimal stent placement for 2 months.
In the remaining 2 cases, endoscopic revision surgery
was planned for frontal sinusitis that was unrespon-
sive to medical therapy.
Two hundred patients (94.3%) were free of disease
when last seen. A single recurrence was observed in
the remaining 12 cases (5.7%; Table 2); all recur-
rences involved the site of the primary lesion, which
was the maxillary sinus in 6 of 92 cases (6.5%), the
nasoethmoidal complex in 4 of 100 cases (4%), and
the frontal sinus in the remaining 2 of 11 cases (18%).
The mean interval between surgical treatment and
diagnosis of recurrence was 19 months (range, 6–70).
All recurrences occurred after purely endoscopic
approaches (6 after type 2 resection, 4 after type 3,
and 2 after type 1). Disease in 8 of 12 patients
(66.7%) was classiﬁed as T3, in 2 patients (16.7%) as
T2, in 1 patient (8.3%) as T4, and in 1 patient (8.3%)
as T1. Four of the 12 patients (33%) had been previ-
ously treated at other institutions by an endoscopic (n
¼ 3) or open approach (n ¼ 1). The recurrences were
treated by a purely endoscopic approach in 10 cases
and by a combined approach in the remaining 2 cases
(Table 2).
There was no statistically signiﬁcant difference
for risk of recurrence considering previous surgery (p
¼ .25), site of origin (p ¼ .15), or stage (p ¼ .47).
DISCUSSION
To the best of our knowledge, this is the largest case
series presented to date in the English- language lit-
erature focusing on the role of endoscopic surgery in
the management of inverted papilloma. In the last
decade, several studies on surgical treatment of this
lesion have conﬁrmed the validity and efﬁcacy of en-
doscopic approaches in obtaining excellent control of
disease with reasonable morbidity.1,2,9,11,13 Recently,
several authors have emphasized the need to modu-
late surgical technique on the basis of the site of
attachment and extension of the inverted papilloma
to minimize recurrence.1,18–20 According to Lund,21 it
is worthwhile remembering that ‘‘the term ‘recur-
rence’ merely indicates residual disease in the major-
ity of cases and is directly related to the surgical
approach and the ‘care’ with which the inverted papil-
loma is removed.’’ Therefore, a recurrence might be
primarily attributed to the inability of the surgeon to
achieve complete resection rather than to the intrin-
sic characteristics of the tumor itself. Consistently
with this statement, a recent position article conﬁrms
that the outcome of treatment relates to how thor-
oughly the diseased mucosa is removed.22
At present, due to the evolution of imaging techni-
ques with the possibility of acquiring multiplanar
reconstructions, it has become easier to preopera-
tively plan surgical procedures. As reported by Sham
et al,23 CT evidence of focal hyperostosis or bony strut
(ie, elongated bony protrusion with narrow base) has
















1 EN E 1 1 70 EN 14
2 – F 3 3 (DRAF III) 40 CO 35
3 – E 3 2 (DRAF IIB) 6 EN 64
4 EXT MA 3 2 12 EN 58
5 EN F 3 2 (DRAF IIB) 6 EN 60
6 EN E 4 2 (DRAF IIB) 41 EN 19
7 MP 3 3 46 EN 12
8 – MM 3 3 19 EN 33
9 – MM 2 2 15 EN 31
10 – E 2 1 8 CO 34
11 – ML 3 3 18 EN 9
12 – MP 3 2 (DRAF III) 15 EN 7
Abbreviations: CO, combined approach; E, ethmoid; EN, endoscopic approach; EXT, external approach; F, frontal sinus; MA, maxillary sinus anterior wall; ML, maxillary sinus
lateral wall; MM, maxillary sinus medial wall; MP, maxillary sinus posterior wall; S, sphenoid sinus.
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a 100% positive predictive value in identifying the
attachment site of the inverted papilloma (Figure 2);
osteitic changes may also be recognized at the site of
origin of inverted papilloma.24,25 Nevertheless, about
20% of CT images are inaccurate in terms of deﬁning
the extension of the tumor.23 In contrast, an MRI has
been shown to be more sensitive than a CT scan in
differentiating inverted papilloma from intrasinusal
retained secretions and identifying areas of possible
malignant degeneration by describing the interface
bone–lesion.22,26 Recent experiences have demon-
strated that the bony alterations used to predict the
site of origin of inverted papilloma can also be identi-
ﬁed by an MRI (Figure 2).27 Moreover, detection of
the ‘‘cerebriform-columnar pattern’’ represents a valu-
able indicator for differential diagnosis, with a posi-
tive predictive value of 95.8%.26 The association of a
columnar appearance with bone changes (remodeling
vs erosion) allows differentiation of inverted papil-
loma from a malignant tumor.26 Despite the accu-
racy of an MRI in deﬁning the signal characteristics
of the lesion, its site of origin and relationships with
critical structures, the technique is not always able
to identify the degree of mucosal involvement in spe-
ciﬁc subsites, especially in those cases in which the
inverted papilloma completely ﬁlls one sinus.16 If
this occurs in the maxillary sinus, it is the type of
endoscopic excision rather than the surgical
approach that must be modulated according to intra-
operative ﬁndings. In fact, in patients with a tumor
arising from the nasoethmoidal complex or maxillary
sinus, we were able to preoperatively predict
whether a pure endoscopic resection was feasible.
On the other hand, whenever massive frontal sinus
involvement was detected, the need for a combined
approach was always considered and discussed with
the patient.
In fact, when faced with involvement of the fron-
tal sinus, the relationship between inverted papilloma
and the sinus is almost invariably assessed intraoper-
atively and the surgical approach is adjusted accord-
ingly. Lesions growing marginally from the ethmoid
into the frontal sinus or ﬁlling a small sinus can be
effectively managed, possibly resorting to a Draf ’s
type II or III procedure. In the presence of lesions
arising at the level of frontal recess, a type IIb frontal
sinusotomy permits drilling the bone underlying the
site of origin of the inverted papilloma and to check
the status of the frontal sinus mucosa. When the site
of origin is located on the frontal sinus posterior wall,
a type III frontal sinusotomy is necessary to increase
the exposure and to reach the entire posterior wall
with double-bent instruments.
Conversely, when the disease extensively involves
the mucosa, especially in a hyperpneumatized frontal
sinus or within a largely pneumatized supraorbital
cell, a combined approach is needed to gain complete
removal of the mucosa and to drill the underlying
bone in the far lateral spaces. Because an inﬂamed
mucosa may be very difﬁcult to differentiate from an
inverted papilloma at endoscopy, whenever the
involvement of a speciﬁc subsite is suspected and/or
may lead to a change in the surgical planning, intrao-
perative frozen sections are strongly recommended.
Other lesions that can be managed by a purely en-
doscopic approach are inverted papillomas with intra-
orbital or intracranial involvement. In recent years,
owing to the evolution of endoscopic expertise in the
management of CSF in addition to malignant tumors
and lesions involving the anterior and middle cranial
fossa, inverted papilloma with a limited intracranial
and/or intraorbital extension can also be managed by
a purely endoscopic approach.28 Even in these cases,
patients scheduled for an endoscopic procedure should
be informed during preoperative counseling regarding
FIGURE 2. Plain CT (A) and contrast-enhanced T1-weighted spin-
echo MR image (B), both on an axial plane. Right maxillary sinus
inverted papilloma; sinus walls are expanded and remodeled. Both
techniques detected a focal strut along the posterior maxillary sinus
wall, representing the attachment site of the lesion (arrows). An
MRI offers clues for the characterization of the lesion (as it displays
the typical cerebriform columnar pattern) and better discrimination
between neoplasm and retained secretions (asterisks).
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the possibility to intraoperatively switch to a com-
bined approach.
A further element that can impact treatment strat-
egy is the detection, preoperatively or at deﬁnitive his-
tology, of SCC. In our experience, only in 2 cases with
preoperative biopsy consistent with an inverted papil-
loma, an MRI identiﬁed ﬁndings consistent with malig-
nancy in the deep portion of the lesion. In 1 case, the
patient was not considered a candidate for surgical
treatment, whereas the second patient underwent cra-
niofacial resection with orbital clearance. In no case of
the present series did a preoperative biopsy reveal SCC
foci associated with inverted papilloma.
In contrast, whenever macroscopic SCC is detected
at deﬁnitive histology, the sites involved should be
carefully evaluated to decide whether or not further
treatment is needed. We planned adjuvant radiother-
apy in 5 of 8 patients with nonmicroscopic, invasive
SCC extending in proximity but not involving critical
areas (skull base, maxillary sinus bony walls with the
exception of the medial one). However, when only mi-
croscopic foci of SCC or carcinoma in situ was identi-
ﬁed, adjuvant radiotherapy was not performed.
In addition, to correct identiﬁcation of the site of or-
igin of the lesion, its spread along the mucosa, and pos-
sible association with SCC, all factors which can
modulate the choice of the surgical approach, another
key point to obtaining radical excision is the use of
appropriate dissection technique. Once the site of origin
has been identiﬁed, in fact, this should be carried along
the subperiosteal plane with subsequent drilling by a
diamond burr of the underlying bone. Only by following
these principles of management can the risk of recur-
rence be minimized.
The recurrence rate of 5.7% observed in our series
of 212 patients favorably compares with data for both
endoscopic and external approaches (4% to 22%).1,8–
10,13,18 All the recurrences in the present series were
observed at the same site of the primary lesion and af-
ter purely endoscopic removal. Although most recur-
rences (66.6%) were diagnosed within 24 months, at
least 5 years of follow-up are recommended. The follow-
up strategy is based upon periodic endoscopic evalua-
tions; integration with an MRI should be scheduled
only when the site of origin of the inverted papilloma is
not visible at endoscopy, a recurrence is detected, or
SCC is identiﬁed at deﬁnitive histology.
Even though inverted papillomas of the frontal sinus
were associated with a higher rate of recurrence (18%)
compared to those of the maxillary sinus and nasoeth-
moidal complex (6.5% and 4%, respectively), no statisti-
cally signiﬁcant difference was observed, possibly due to
the limited number of cases. No recurrence occurring pri-
marily in the frontal sinus was observed when a com-
bined technique was used. Although this observation
reinforces the importance of accurate selection of the sur-
gical approach, it should not lead one to conclude that
OPF is the ﬁrst choice in all inverted papillomas















Kaza32 51 (51 En) 6 10 (19.6%) 10 (19.6%)* 0 (0%)
Lee33 43 (43 En) 9 1 (2.3%) 1 (2.3%) 0 (0%)
(1 CSF-leak)
Wolfe34 50 (31 En, 19 Co) 12 1 (2.0%) 1 (2.0%) 0 (0%)
(1 CSF-leak)
Buchwald35 42 (34 En, 8 Co) 9 3 (7.2%) 2 (4.8%) 1 (2.4%)
(2 facial numbness) (1 epiphora)
Minovi13 81 (61 En, 20 Co) 12 0 (0%) 0 (0%) 0 (0%)
Holzmann36 51 (51 En) 60 2 (3.9%) 1 (1.9%) 1 (1.9%)
(1 epistaxis) (1 V2 paresthesia)
Sautter9 49 (49 En) Not reported 1 (2.0%) 1 (2.0%) 0 (0%)
(mean: 16) (1 CSF-leak)
Woodworth10 114 (75 En, 39 Co) 7 4 (3.5%) 4 (3.5%) 0 (0%)
(4 CSF-leak)
Mackle37 55 (32 En, 23 Co) 36 4 (7.2%) 2 (3.6%) 2 (3.6%)
(2 transient epiphora) (1 V2 paresthesia, 1 frontal mucocele)
Kim8 94 (94 En) 10 3 (3.2%) 2 (2.1%) 1 (1.1%)
(2 periorbital swelling) (1 epiphora)
Durucu38 49 (23 En, 26 Co) 16 10 (20%) 3 (6.1%) 7 (13.9%)
(3 orbital pain) (6 epiphora, 1 scarring)
Sham39 56 (40 En, 16 Co) 24 4 (7.1%) 0 (0%) 4 (7.1%)
(3 sinusotomy closure, 1 oroantral ﬁstula)
Present series 212 (198 En, 14 Co) 24 20 (9.4%) 8 (3.7%) 12 (5.7%)
(6 CSF-leak, 2 epistaxis) (6 mucocele, 4 epiphora, 2 frontal sinusitis)
Abbreviation: CSF, cerebrospinal ﬂuid.
*15 early complications (3 CSF, 3 temporary frontal hypoesthesia, 2 orbital fat exposure, 2 periorbital hematoma, 2 maxillary neuralgia, 2 cheek cellulitis, 1 malar rush) occurred
in 10 patients.
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involving the frontal sinus. In fact, OPF is indicated only
in selected cases with extensive frontal sinus and/or
supraorbital cell involvement. This approach is indeed
characterized by morbidity that should not be underesti-
mated, including unintentional fracture or incorrect
placement of frontal sinus anterior wall, adverse aes-
thetic consequences due to skin incision and/or changes
of frontal contour (depression, embossment), frontal an-
esthesia and supraorbital nerve neuralgia.29–31
Overall, 20 complications (9.4%) were observed, and
were classiﬁed as early (8 cases, 3.7%; ie, occurring intra-
operatively and in the immediate postoperative time),
and late (12 cases, 5.7%). According to a review of the lit-
erature (Table 3), the overall complication rate ranges
between 0% and 20% (mean, 6.5%), with early and late
complication rates ranging between 0% and 19.6%
(mean, 4.0%) and 0% and 13.9% (mean, 2.5%), respec-
tively. It is quite evident that the somewhat higher com-
plication rate observed in the present series is mainly
due to the late complications. Some speculations may be
offered to explain this ﬁnding. First of all, the length of
our follow-up, which reaches 192 months with a mean of
53.8 months, can justify late onset complications.
Another element that needs to be considered is the rela-
tively high number of CSF leaks (6 cases) compared to
data in the literature. If we consider that our surgical
technique includes subperiosteal dissection of the lesion
and drilling of the underlying bone, both of which are
key elements in achieving a low recurrence rate, it is in-
tuitive that these steps also expose a patient with an
inverted papilloma originating from or involving the an-
terior skull base to a major risk of dural lesion.
CONCLUSIONS
Advances in imaging techniques, increased experience
with endoscopic surgery, and careful analysis of the pat-
tern of recurrence have helped to reﬁne modern surgical
management of inverted papilloma. Endoscopic surgery
is now the ﬁrst choice in the treatment of inverted papil-
loma, owing to the multi-angle magniﬁed view of the sur-
gical ﬁeld, the availability of powered instrumentation
and the attachment-oriented surgical strategy, with
decreased morbidity and hospitalization time compared
to external approaches. In our opinion, in centers with
longstanding experience in endoscopic sinus surgery the
vast majority of cases can be managed endoscopically;
only in patients with a tumor showing extensive involve-
ment of the frontal sinus may a switch to a combined
approach be required. The analysis of recurrences dem-
onstrates that, although the highest risk is in the ﬁrst 2
postoperative years, it is advisable to extend follow-up
for at least 5 years.
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